|
My
research covers two areas:
1) The interplay between viruses and
chaperones:
Like cellular proteins, viral proteins generated
during the course of an infection are likely to require chaperones
to attain the native, functional state. I am examining the chaperone
requirements of two members of the Picornavirus family, Poliovirus
and Rhinovirus. The interaction of proteins from these two viruses
with the chaperone machinery is likely to be interesting because quickly
after infection host protein synthesis is turned off and only viral
proteins are produced. Therefore, the repertoire of client proteins
for chaperones will consist of a very limited, high abundance pool
of viral proteins. In addition, the assembly of higher order complexes,
such as the viral capsid, may require chaperones for formation.
2) Cross presentation:
Direct presentation refers to a mechanism
by which peptides generated from degradation of endogenous
cellular proteins are displayed on the cell surface in complex with
MHC class I. This mechanism enables the immune system to "see"
what is occurring inside the cell so that infected or transformed
cells can be rapidly identified and eliminated. Cross presentation,
on the other hand, is a mechanism by which cells display peptides
from an exogenous source (i.e. an infected neighboring cell)
on their MHC class I. While direct presentation is found in nearly
all cell types, Cross presentation mainly occurs in cells of the
immune system which specialize in antigen presentation. I am using
an in vitro system to try and understand the mechanism of Cross
Presentation
Publications:
[1] Geller R, Vignuzzi M, Andino R, Frydman J. Evolutionary
constraints on chaperone-mediated folding provide an antiviral approach
refractory to development of drug resistance. Genes Dev 2007;21
(2):195-205.
[2] Tam S, Geller R, Spiess C, Frydman J. The chaperonin TRiC
controls polyglutamine aggregation and toxicity through subunit-
specific interactions. Nat Cell Biol 2006;8 (10):1155-62.
[3] Khakoo SI, Geller R, Shin S, Jenkins JA, Parham P. The D0
domain of KIR3D acts as a major histocompatibility complex class
I binding enhancer. J Exp Med 2002;196 (7):911-21.
[4] Geller R, Adams EJ, Guethlein LA, Little AM, Madrigal JA, Parham
P. Linkage of Patr-AL to Patr-A and- B in the major histocompatibility
complex of the common chimpanzee (Pan troglodytes). Immunogenetics
2002;54 (3):212-5.
|